April 2026

Healthcare providers are expert pattern recognizers—until the pattern belongs to them. Headaches that only show up on clinic days, sleep that never feels restorative, a shorter fuse with the EHR or a colleague we respect: we rationalize, push through, and hope the weekend fixes it. Often, it doesn’t.

Clinician stress is not a personal weakness; it’s a predictable physiological response to chronic job strain. Unchecked, it erodes empathy, clouds decision‑making, and increases risk—for clinicians and for patients. Stress Awareness Month is an invitation to notice and act early and protect the quality and safety of care.

What stress looks like before it becomes burnout

Even when evaluation is “normal,” stress leaks into practice. Watch for:

• Emotional/behavioral: rising irritability or cynicism, emotional numbing, withdrawing from team touchpoints.
• Quality/safety: slipping documentation quality, more rework, near‑misses that surprise you.
• Somatic: fatigue, headaches, GI symptoms—especially when they track with workload/call cycles and ease on protected time off.

Why primary care is uniquely exposed

Primary care specialty concentrates the very ingredients that amplify stress:

• Relational continuity (emotional load over years, not minutes)
• High inbox and EHR demand (often spilling after hours)
• Tight scheduling with competing quality/productivity metrics
• Staffing gaps that convert “optional” tasks into mandatory extras

Fast ways to tell if stress is driving what you feel
Use clinical reasoning on yourself:

• Do symptoms worsen with clinic intensity and lighten on lighter weeks?
• Are PHQ‑9/GAD‑7 mild yet you still feel drained, detached, or on edge?
• Do you feel less like yourself in patient rooms you used to love?

If “yes,” treat it like any safety risk: acknowledge → measure → plan → follow up.

What You Can Do

Normalize help: it’s protective, not punitive
Normalizing that somatic symptoms often substitute for named distress. Clinicians regularly avoid care due to misunderstanding.

• Use peer support or EAP sooner, not later—especially after adverse events.
• Share accurate licensure language in your group: most boards focus on current impairment, not prior treatment.
• Seeing a therapist, psychiatrist, coach, or using EAP is legally safe
• Safe‑haven pathways exist in many states
• Leaders: model micro‑affirmations (“Thanks for surfacing that near‑miss—that is safety”) and close the loop on reported pain points.

How to talk with a colleague you’re worried about
Keep it warm, factual, and actionable. For example: “I’ve noticed your notes are running late, and you’ve taken on more after‑hours messages. I can cover your inbox block Wednesday so you can catch up. What else would help this week?”

• Offer one concrete swap (coverage, MA time, admin block).
• Avoid pathologizing; focus on workload and safety.
• Share support options without pressure.

Bottom Line

You’re not “failing” if you feel depleted. You’re experiencing a normal human response to sustained clinical load. The remedy isn’t grit alone—it’s better workload design, brief physiological resets, and a culture that treats clinician well‑being as a core patient safety practice. Small steps, repeated, protect the care you’re proud to deliver—and the person who delivers it.

Minority Health Month reminds us that inequities are not only medical—they are emotional, structural, and cumulative. Depression is common, but depression that doesn’t improve—treatment‑resistant depression (TRD)—is especially overlooked in communities of color. Symptoms may be explained away as stress, spiritual burden, or somatic complaints. Many individuals reach care late, are under-treated, or not treated at all.

Yet TRD is not rare, affecting roughly a third of people treated for major depression. And because minoritized groups often face delayed diagnosis, limited access, fragmented follow-up, or under-dosing of antidepressants, they are disproportionately at risk. Recognizing TRD early—and responding with structured, evidence‑based steps—helps close both outcome gaps and trust gaps.

Why TRD Matters in Minority Health
Untreated or partially treated depression drives:

• Higher burden of chronic disease
• Worse diabetes and cardiovascular control
• Poor medication adherence
• Lower engagement in care
• Higher rates of disability and emergency utilization

Recognizing Treatment‑Resistant Depression
Treatment-resistant depression means that the patient has not achieved meaningful improvement after two adequate antidepressant trials at therapeutic dose and duration. This is not a character flaw, spiritual failure, or “noncompliance.” 

To identify TRD earlier, clinicians can watch for subtle flags:

• Persistent fatigue despite “normal” labs
• Lingering anxiety, irritability, or hopelessness
• Sleep/wake cycle disruption that’s not improving
• Recurrent somatic complaints (e.g.headache and stomach pain) that track with mood
• Flattened affect or emotional exhaustion in visits
• Repeated primary care visits without clear medical explanation

These somatic presentations mean depression—and especially TRD—can go unrecognized unless clinicians intentionally look for it.

Why TRD Disproportionately Affects Minoritized Patients
Several system-level issues contribute:

• Underdiagnosis due to somatic presentation or clinician bias
• Under-treatment (lower starting doses, limited titration)
• Less access to psychotherapy or psychiatry
• Cultural stigma and mistrust of mental health labeling
• Social determinants such as unstable housing, financial strain, chronic stress, and caregiver burden
• Fragmented follow‑up after starting medication

Evidence‑Based Management Steps (Primary Care Friendly)
TRD management doesn’t have to be specialized or complex. The keys are systematic reassessment, structured decision-making, and culturally responsive care.

• Use Scales like the PHQ-9 and HAM-D to track symptoms.
  • These are validated and reliable tools for assessing depression severity
  • They are widely used to improve patient outcomes and facilitate referrals for mental health services.
  • They can be filled out in waiting rooms before appointments.
• Recheck the basics
  • Was the medication taken consistently for 6–8+ weeks?
  • Was the dose high enough?
  • Are there co-occurring issues like untreated anxiety, PTSD, chronic pain, or insomnia?
• Optimize the current therapy
  • Titrate to therapeutic dose (many patients never get there).
  • Consider switching within class (SSRI to another SSRI) or across class (SSRI to SNRI)
• Add-on augmentation options
  • Do not use benzodiazepines - more than 50% of people started on benzodiazepines stay on them indefinitely with limited continued effect. 
  • Bupropion (energy, motivation, smoking cessation benefit)
  • Mirtazapine (sleep, appetite, weight gain useful for some)
  • Buspirone (especially with comorbid anxiety)
  • Second-generation antipsychotic augmentation ((low-dose aripiprazole, brexpiprazole; watch cost/coverage)
• Offer therapy - and help overcome access barriers
  • Normalize therapy (part of "whole-person care").
  • Offer tele-therapy options 
  • Connect patients to culturally matched or trauma-informed therapists when possible
• Address social conditions driving relapse
  • This is essential for minorities facing chronic stress exposures
  • Food insecurty: nutrition support programs
  • Housing instability: community resources
  • Loneliness: social support referral
  • Transportation: medical transport
  • Caregiver strain: caregiver support programs    
• Consider referral for advanced therapies when available:
  • TMS (Transcranial magnetic stimulation)
  • Esketamine (requires specialty facilities)
  • Psychiatric co-management
  • But even without these, simple changes like dose optimization and augmentation are highly effective. 

Bottom Line

In Minority Health Month, treat TRD like a clinical plus equity problem: actively look for somatic/atypical presentations, assume under-treatment until proven otherwise, optimize dose and duration early, augment or switch systematically, make therapy and social supports truly reachable, and escalate when needed - because structured steps and culturally responsive care close outcome gaps and rebuild trust. 

Article and source references available upon request.

Primary care remains central to controlling sexually transmitted infections (STIs), yet two persistent gaps continue to drive transmission and disparities in New York State:

• Asymptomatic infections go undetected, sustaining community spread.
• Treatment that doesn't align with CDC recommendations remains widespread, especially azithromycin overuse, undermining treatment efficacy and fueling reinfection and antimicrobial resistance.

New WHO, CDC, and NYSDOH actions released between 2024–2025 offer an updated blueprint for screening, treatment, and partner management that primary care must now integrate into routine practice.

The Problem We Can’t See: Asymptomatic STIs Drive Ongoing Transmission

A large proportion of chlamydia and gonorrhea cases remain asymptomatic, prolonging undiagnosed infectious periods, increasing complications of infection, and allowing silent transmission across communities. The WHO’s July 2025 asymptomatic STI guidance emphasizes proactive screening of high‑risk groups—pregnant individuals, adolescents/young adults (not just females) aged 10–24, sex workers, and men who have sex with men (MSM)—with annual to 6‑month intervals depending on risk and service capacity. The WHO also recommends healthcare systems integrate screening into primary care and antenatal care.

NYSDOH echoed this message during STI Awareness Week 2025, emphasizing that lack of symptoms does not indicate lack of infection and urging regular screening for sexually active New Yorkers. 

The Problem We Create: Azithromycin Overuse and Suboptimal Treatment

Despite updated CDC treatment recommendations, primary care prescribers continue to underuse doxycycline and ceftriaxone, defaulting instead to azithromycin monotherapy. A 2025 Annals of Family Medicine study reviewing over 8,800 primary‑care cases (2018–2022) found:

• Only 14% of chlamydia cases received recommended doxycycline
• Only 38.7% of gonorrhea cases received recommended ceftriaxone
• Azithromycin was used in 83.9% (chlamydia) and 59.5% (gonorrhea)—despite CDC removal from preferred regimens

Treatment delays were also longer for non Hispanic Black patients and for adults aged 50–59, highlighting systemic inequities.

CDC guidance remains clear:

• Chlamydia: doxycycline 100 mg BID × 7 days
• Gonorrhea: ceftriaxone 500 mg IM × 1 dose

Syphilis—Screen Early, Treat Right, Protect Pregnancies

New York State is experiencing a record rise in congenital syphilis, including infant deaths outside NYC reported in 2025, reflecting missed screening opportunities and care gaps. To address this, NYS enacted a mandatory third trimester syphilis screen beginning May 3, 2024, in addition to screens at the first prenatal visit and at delivery. This requirement must be reflected in primary care prenatal workflows, EMR reminders, and standing orders.

Complicating this effort, a July 2025 Bicillin L-A recall and national shortage prompted CDC and NYSDOH to urge clinicians to:

• Reserve penicillin exclusively for pregnant patients and congenital syphilis cases,
• Use doxycycline appropriately for non pregnant adults,
• Avoid using Bicillin C R, which is not effective for syphilis. 

Expedited Partner Treatment (EPT) —Tools to Break Reinfection Cycles

NYS has strengthened and expanded its support for Expedited Partner Treatment:

• EPT campaign launched in January 2024, increasing public and clinical awareness.
• Public Health Law §2312 (2024) affirms that clinicians may treat partners of patients diagnosed with chlamydia, gonorrhea, and trichomoniasis without examination.
• 2025 regulatory updates and new guidance clarify eligibility, prescribing, medication options, protections for clinicians, and integration with doxy PEP considerations.
• CDC verifies EPT permissibility and legal framework in NYS. 

Doxy PEP & Extragenital Testing (Optional Enhancers)

NYS and CDC communications increasingly reference Doxy PEP and more routine extragenital NAATs where exposure indicates—two strategies that complement asymptomatic screening and correct treatment. Incorporating these into risk based protocols can reduce reinfections while stewardship efforts move prescribers away from azithromycin.

Practical Steps for NYS Primary Care in 2026

1. Normalize Asymptomatic Screening
   1. Screen adolescents/young adults, MSM, and sex workers annually or every 6 months depending on risk and prevalence.
   2. Expand access to rectal and pharyngeal NAATs when exposure suggests.
2. Treat by the Book—Remove Azithromycin Defaults
   1. Update EMR order sets; remove azithromycin quick picks for chlamydia/gonorrhea.
   2. Automatically link CDC dosing guidelines in STI order workflows.
3. Operationalize EPT
   1. Preload EPT prescriptions for chlamydia, gonorrhea, and trichomoniasis, with educational materials.
   2. Offer take home medication packs when feasible.
4. Prioritize Pregnancy Safety
   1. Ensure every prenatal patient receives three syphilis tests.
   2. Reserve penicillin for pregnant patients per recall guidance. 
5. Address Treatment Delays and Equity Gaps
   1. Use EMR alerts for untreated positive STI results after 24–48 hours.
   2. Create rapid response workflows for high risk populations, given known delays in treatment for non Hispanic Black individuals and older adults. 

Conclusion

New York faces two simultaneous threats to STI control: invisible infections that go undetected and visible treatment patterns that ignore evidence based recommendations. Strengthening screening for asymptomatic patients, replacing outdated azithromycin regimens with CDC recommended therapies, expanding EPT use, and aligning with NYSDOH congenital syphilis requirements will significantly reduce morbidity and transmission.

With Bicillin L-A shortages persisting and congenital syphilis rising, accurate diagnosis, timely treatment, and robust partner management are more urgent than ever. NYS primary care practices can meet this moment by hardwiring these updated best practices into everyday care.

Patients prepare advance directives in an effort to maintain autonomy during periods of incapacity or at the end of life. Advance directive documents are specific to the state in which the patient lives, but an effective strategy in the family physician's office involves more than filling out a form. 

Physician barriers to completing an advance directive include lack of time and discomfort with the topic. On the patient's part, lack of knowledge, fear of burdening family, and a desire to have the physician initiate the discussion are common barriers.

Once the advance directive is complete, barriers to implementation include vague language, issues with the proxy decision maker, and accessibility of the advance directive. Overcoming these barriers depends on effective communication at multiple visits, including allowing the patient the opportunity to ask questions. Involving the family or a proxy early and over time can help the process.

And with National Healthcare Decisions Day on April 16, it’s a good reminder to consider having those conversations this month with patients. 

It may be helpful to integrate advance directive discussions at selected stages of the patient's life and as health status changes.

The Conversation Project by the Institute for Healthcare Improvement has a variety of helpful resources and informational documents you can share with your patients. 

Get started here at The Conversation Project.

Independent Health develops outreach campaigns to members in need of certain preventive services and to help make them aware of our programs and resources to help them maintain or improve their health. Here is a summary of the current outreach campaigns underway. 

As a reminder, Independent Health has contracted with Integra Partners to provide its network for Durable Medical Equipment, Prosthetics, Orthotics and Medical Supplies (DMEPOS) services, effective April 1, 2026. This partnership offers comprehensive service for our members’ medical equipment and supply needs. 

Remember to view our up-to-date policies online.